13 research outputs found
Racial difference in Acylation Stimulating Protein (ASP) correlates to triglyceride in non-obese and obese African American and Caucasian women
Β© 2009 Scantlebury-Manning et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens
sj-docx-2-sjp-10.1177_14034948241240823 β Supplemental material for Association of cancer with functional decline at old age: a longitudinal study in Danish twins
Supplemental material, sj-docx-2-sjp-10.1177_14034948241240823 for Association of cancer with functional decline at old age: a longitudinal study in Danish twins by Afsaneh Mohammadnejad, Jesper Ryg, Marianne Ewertz, Juulia JylhΓ€vΓ€, Jacob vB. Hjelmborg and AngΓ©line Galvin in Scandinavian Journal of Public Health</p
sj-docx-1-sjp-10.1177_14034948241240823 β Supplemental material for Association of cancer with functional decline at old age: a longitudinal study in Danish twins
Supplemental material, sj-docx-1-sjp-10.1177_14034948241240823 for Association of cancer with functional decline at old age: a longitudinal study in Danish twins by Afsaneh Mohammadnejad, Jesper Ryg, Marianne Ewertz, Juulia JylhΓ€vΓ€, Jacob vB. Hjelmborg and AngΓ©line Galvin in Scandinavian Journal of Public Health</p
GRIN: " GRoup versus INdividual physiotherapy following lower limb intra-muscular Botulinum Toxin-A injections for ambulant children with cerebral palsy: An assessor-masked randomised comparison trial": Study protocol
Background: Cerebral palsy is the most common cause of physical disability in childhood. Spasticity is a significant contributor to the secondary impairments impacting functional performance and participation. The most common lower limb spasticity management is focal intramuscular injections of Botulinum Toxin-Type A accompanied by individually-delivered (one on one) physiotherapy rehabilitation. With increasing emphasis on improving goal-directed functional activity and participation within a family-centred framework, it is timely to explore whether physiotherapy provided in a group could achieve comparable outcomes, encouraging providers to offer flexible models of physiotherapy delivery. This study aims to compare individual to group-based physiotherapy following intramuscular Botulinum Toxin-A injections to the lower limbs for ambulant children with cerebral palsy aged four to fourteen years.Methods/Design: An assessor-masked, block randomised comparison trial will be conducted with random allocation to either group-based or individual physiotherapy. A sample size of 30 (15 in each study arm) will be recruited. Both groups will receive six hours of direct therapy following Botulinum Toxin-A injections in either an individual or group format with additional home programme activities (three exercises to be performed three times a week). Study groups will be compared at baseline (T1), then at 10 weeks (T2, efficacy) and 26 weeks (T3, retention) post Botulinum Toxin-A injections. Primary outcomes will be caregiver/s perception of and satisfaction with their child's occupational performance goals (Canadian Occupational Performance Measure) and quality of gait (Edinburgh Visual Gait Score) with a range of secondary outcomes across domains of the International Classification of Disability, Functioning and Health.Discussion: This paper outlines the study protocol including theoretical basis, study hypotheses and outcome measures for this assessor-masked, randomised comparison trial comparing group versus individual models of physiotherapy following intramuscular injections of Botulinum Toxin-A to the lower limbs for ambulant children with cerebral palsy.Trial registration: ACTRN12611000454976